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Abstract
Background: Overviews of reviews (i.e., overviews) compile information from multiple systematic reviews to
provide a single synthesis of relevant evidence for healthcare decision-making. Despite their increasing popularity,
there are currently no systematically developed reporting guidelines for overviews. This is problematic because the
reporting of published overviews varies considerably and is often substandard. Our objective is to use explicit,
systematic, and transparent methods to develop an evidence-based and agreement-based reporting guideline for
overviews of reviews of healthcare interventions (PRIOR, Preferred Reporting Items for Overviews of Reviews).
Methods: We will develop the PRIOR reporting guideline in four stages, using established methods for developing
reporting guidelines in health research. First, we will establish an international and multidisciplinary expert advisory
board that will oversee the conduct of the project and provide methodological support. Second, we will use the
results of comprehensive literature reviews to develop a list of prospective checklist items for the reporting
guideline. Third, we will use a modified Delphi exercise to achieve a high level of expert agreement on the list of
items to be included in the PRIOR reporting guideline. We will identify and recruit a group of up to 100
international experts who will provide input into the guideline in three Delphi rounds: the first two rounds will
occur via online survey, and the third round will occur during a smaller (8 to 10 participants) in-person meeting
that will use a nominal group technique. Fourth, we will produce and publish the PRIOR reporting guideline.
Discussion: A systematically developed reporting guideline for overviews could help to improve the accuracy,
completeness, and transparency of overviews. This, in turn, could help maximize the value and impact of overviews
by allowing more efficient interpretation and use of their research findings.
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Background
Overviews of reviews specific to healthcare interventions
(sometimes referred to as “overviews of systematic re-
views,” “reviews of reviews,” “reviews of systematic re-
views,” or “umbrella reviews”; hereafter referred to as
“overviews”) use explicit and systematic methods to
search for, identify, extract data from, and analyze the
results of multiple related systematic reviews (Table 1).
Their aim is to provide a single synthesis of systematic
review evidence to answer different types of questions
related to the efficacy, effectiveness, and/or safety of
healthcare interventions for preventing or treating vari-
ous clinical conditions [1]. Because overviews have been
gaining momentum as an increasingly popular know-
ledge synthesis product, methods for conducting over-
views have evolved in recent years [2–6]. For example,
in 2016, we published a scoping review summarizing
existing guidance for conducting overviews of healthcare
interventions [7], and we used the results to update the
chapter on overview methods in the Cochrane Handbook
for Systematic Reviews of Interventions [1]. Despite ad-
vances in methods for conducting overviews, the report-
ing of overviews varies considerably and is often
substandard (Table 2) [2–4].
A reporting guideline is defined as “a checklist, flow
diagram, or explicit text to guide authors in reporting a
specific type of research, developed using explicit meth-
odology” [8]. To date, we are not aware of any published
guidance that was developed based on the evidence-
based and agreement-based process recommended by
the Enhancing QUAlity and Transparency Of health Re-
search (EQUATOR) Network [8]. We are, however,
aware of several relevant documents that narratively de-
scribe (based on personal experience and principles of
“good practice”) issues related to reporting overviews.
Onishi and Furukawa [9] developed a checklist for over-
views of reviews focused on clinical topics based on the
recommendations of Cochrane [10], the Preferred
Reporting Items for Systematic reviews and Meta-
Analyses (PRISMA) statement [11], and the AMSTAR
(A MeaSurement Tool to Assess systematic Reviews)
quality assessment tool [12]. Bougioukas et al. [13] pub-
lished a checklist (PRIO, Preferred Reporting Items for
Overviews of Systematic Reviews) with specific emphasis
on harms reporting that was designed by combining
recommendations from PRISMA [11], PRISMA-harms
[14], PRISMA-protocols (PRISMA-P) [15], and other
relevant documents. The same research group published
the first available guidance on the reporting of abstracts
for overviews of reviews of healthcare interventions [16],
generated by combining features of PRISMA for ab-
stracts [17], the PRIO checklist [13], important features
of published abstracts identified in their literature
search, and expert input. Li et al. [18] produced a check-
list for overviews of reviews of healthcare interven-
tions based on the recommendations in the Cochrane
handbook [10], PRISMA statement [11], and the
Overview Quality Assessment Questionnaire (OQAQ)
[19]. Finally, Singh [20] published a reporting check-
list for metareviews (MARQ, Metareview Assessment
of Reporting Quality checklist), a type of overview
that descriptively compares the reporting characteris-
tics of systematic reviews, based on AMSTAR [12]
and Cochrane guidance [10].
An abstract for STROVI (Standards for Reporting of
Overviews of Reviews and Umbrella Reviews statement)
was presented at the 2017 Cochrane Colloquium [21],
but our informal contact with the authors indicated that
to date further work on the project has not been under-
taken. We have included the primary author of the
STROVI abstract, as well as authors of the other previ-
ously mentioned published checklists, as participants in
our Delphi process, based on their interest and expertise
in overview methodology. While the aforementioned
guidance can be a good starting point for authors pre-
paring overviews, there is a lack of clarity about which
might be the best to use and under what circumstance.
In addition, much of the evidence used to develop the
guidelines has since been updated (e.g., a new Cochrane
chapter on overviews was published [1], and AMSTAR 2
[22] was developed). There is a need for an up-to-date,
rigorously developed [8] reporting guideline for over-
views that can be endorsed by funders and publishers [8]
to help authors report their methods and results in a
consistent, complete, and transparent way [8, 23, 24].
This, in turn, could help end-users to better assess the
reliability, validity, and applicability of overview results
when making healthcare decisions [8, 25].
Our objective is to develop an evidence-based and
agreement-based reporting guideline for overviews
Table 1 Types of questions about healthcare interventions that overviews can examinea
1 Different interventions for the same condition or population.
2 Different approaches to the application of the same intervention for the same condition or population.
3 Same intervention for different conditions or populations.
4 Adverse effects of an intervention for one or more conditions or populations.
5 The same intervention for the same condition or population, where different outcomes or time points are addressed.
aFrom Pollock et al. 2019 Cochrane Handbook chapter on overviews of reviews [draft] [1]
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(PRIOR, Preferred Reporting Items for Overviews of Re-
views) using explicit, systematic, and transparent
methods, as recommended by the EQUATOR Network
[8]. Because the unit of analysis differs from that of sys-
tematic reviews, we plan to develop the guideline de
novo, rather than undertaking a PRISMA extension.
Though we expect that some of the reporting guidance
will be similar to PRISMA, the development of a stand-
alone guideline will allow us to focus on the particular
challenges in reporting overviews and to facilitate future
guideline extensions (e.g., for diagnostic or prognostic
accuracy overviews, etiology overviews). This guideline
will consist of a “minimum essential set of items that
should be reported” in overviews of healthcare interven-
tions [8]. The PRIOR guideline will focus on overviews
that examine the efficacy, effectiveness, and/or safety of
healthcare interventions and that present narrative sum-
maries and/or meta-analyses of quantitative outcome
data. The target audience of the PRIOR reporting guide-
line will be overview authors, peer reviewers, journal edi-
tors, and healthcare decision-makers.
Methods
This study will follow the key steps recommended by
the EQUATOR Network for developing reporting guide-
lines in health research [8], which have been used to
successfully develop reporting guidelines for other similar
knowledge syntheses such as systematic reviews [11] and
network meta-analyses [26]. We will develop the reporting
guideline in four stages: (1) project launch, (2) literature
review, (3) modified Delphi exercise, and (4) development
of the guidance statement. These stages are illustrated in
Fig. 1 and described below. We will record protocol
amendments and describe these in our final manuscript.
We have registered our intent to develop the PRIOR
reporting guideline for overviews on the EQUATOR Net-
work website (“reporting guidelines under development”
section) [27]. The EQUATOR Network encourages regis-
tration of all reporting guidelines and extensions under
development to raise awareness and help to prevent dupli-
cation. Before launching the project, we obtained ethics
approval from the University of Alberta Health Research
Ethics Board (#Pro00086094).
Project launch
At project launch (December 2018), we established a core
project team who will be responsible for the day-to-day op-
erations of the planned project, consisting of methodolo-
gists with expertise in overview methodology and the
development of reporting guidelines (MP [Canada]; LH
[Canada]; RMF [Portugal]; DP [Germany]; ACT [Canada]),
and research staff (AG and MG [Canada]).
Table 2 Percentage of overviews (published up to 2016 or 2017) reporting on key aspects of methods and results
Reporting item Percentage of overviews reporting the item (%)
Indicate that they are working from a protocol [4] 22
Rationale [4] 60
Explicit statement of objectives [4] 56
PICO criteria for eligibility [4] 44
Primary outcome [28] 29
Databases and search dates [28] 74
Full search strategy [4] 36
Circumstances in which primary studies would be considered [4] 6
Description of methods used for all steps of screening [28] 69
Description of methods used for data extraction [28] 67
Description of methods used to assess quality or risk of bias [28] 78
Description of methods for addressing overlapping SRs in overviews [4] 44
Description of methods for addressing discordant SRs [4, 28] 4–6
Description of the synthesis methods 26
Description of included SRs (adequate detail to be replicable) [4] 20
Methodological quality of included SRs [4] 76
Methodological quality of primary studies contained within included SRs [4] 22
Certainty of evidence of outcome data [4] 34
Conflicts of interest statement [28] 82
Source of funding [28] 74
Data from Lunny et al. (n = 50 overviews) [4] and an ongoing review by Pieper et al. (n = 100 overviews) [28]
SR systematic review
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We then established an international and multidisciplin-
ary expert advisory board, with expertise in overview
methodology and the development of reporting guidelines,
who will advise on the development of PRIOR: Dr. David
Moher (Canada); Dr. Tianjing Li (USA); Dr. Sue Brennan
(Australia). The advisory board will be consulted regularly
throughout the guideline development process. They will
be asked to recommend relevant documents for the
literature review; nominate participants for the Delphi ex-
ercise, review the checklist items for inclusion in the first
round of the Delphi exercise, provide feedback after each
round of the Delphi exercise (e.g., interpret results of the
previous round, approve content for the next round), help
plan and co-facilitate the in-person meeting, contribute to
the production of the final reporting guideline, and assist
with dissemination and knowledge translation activities.
Fig. 1 Four stages of the reporting guideline
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Literature review
To support the development of the PRIOR reporting
guideline, we will conduct a methodological SR examin-
ing the quality of reporting of a sample of overviews of
healthcare interventions published from 2012 to 2016
(in progress) [28]. To ensure that the most recently
available data are used to inform the PRIOR guideline,
we have supplemented our own data with those recently
published by Lunny et al. in 2019 [4]. We will also
search for and summarize methodological documents
related to conducting and reporting overviews (e.g., doc-
uments that provide guidance for reporting overviews,
documents that summarize methods used to conduct
overviews, and empirical studies that evaluate methods
for conducting overviews) (in progress). To identify rele-
vant methodological documents, we will use and expand
upon the most relevant search strategies contained
within the scoping review by Pollock et al. [7], the meth-
odological SR by Pieper et al. [28], and the evidence map
by Lunny et al. [5, 6]. Our searches, which will continue
until the final version of the PRIOR guideline is com-
pleted, will consist of: web searches (Google Scholar);
reference tracking [29, 30]; monitoring article alerts;
hand-searching websites, conference proceedings, and
personal files; and asking experts (e.g., advisory board
members; Delphi participants during the first survey
round) for relevant articles. Two independent reviewers
will assess titles and abstracts and all potentially relevant
full-text articles for inclusion, with discrepancies re-
solved by consensus or third party adjudication. Results
of the literature review will be used to develop and refine
a list of checklist items that a panel of expert partici-
pants will assess for inclusion in the PRIOR reporting
guideline.
Modified Delphi exercise
A panel of experts (i.e., “participants”) will participate in
a modified Delphi exercise to achieve a high level of
agreement (≥ 70%) on the list of items to be included in
the PRIOR reporting guideline [8]. The participants will
provide feedback on potential items during three Delphi
rounds, using structured feedback between rounds to
help reconcile individual opinions and achieve group
agreement [31–33]. Three rounds are likely to result in
convergence of opinions between participants [32, 33].
The first two Delphi rounds will include all participants
and occur online via self-administered survey; the third
Delphi round will include a smaller subset of the partici-
pants (i.e., “expert panelists”) and occur during an in-
person meeting that will use a nominal group technique
(i.e., a formal consensus technique where expert panel-
ists systematically review, discuss, and re-rate outstand-
ing items) to achieve agreement [33, 34]. Should a high
level of agreement (≥ 70%) not be reached following the
in-person meeting, we may implement a third online
survey among the expert panelists to assist in achieving
agreement. Before the study, we will pilot test the sur-
vey’s usability, clarity, and face validity by sending it to
five individuals familiar with overview methods but un-
involved in the current project. Their feedback will be
used to revise the survey format and checklist items as
needed.
Participant recruitment
We will use a purposive sampling technique [31] to identify
and recruit a panel of up to 100 participants with experi-
ence coordinating, conducting, reviewing, disseminating,
and/or using overviews of healthcare interventions (e.g., ed-
itors, authors, peer reviewers, and end-users of published
overviews such as guideline developers). We will aim to re-
cruit international participants who have diverse roles (e.g.,
researchers, healthcare professionals, patients, journal edi-
tors, policy-makers, funding agency representatives) and are
employed in a range of settings (e.g., universities, hospitals,
government, non-profit organizations, for-profit organiza-
tions). Participants will form a single panel for the analysis
of survey results, feedback between rounds, and criteria for
agreement. A list of potential participants will be prioritized
by the core project team, in order to provide representation
from our populations of interest (i.e., editors, authors, peer-
reviewers, end-users) and major evidence synthesis centers
(i.e., Joanna Briggs Institute, Canadian Agency for Drugs
and Technologies in Health, Campbell Collaboration,
Cochrane, Agency for Healthcare Research and Quality Ef-
fective Health Care Program, Canadian Task Force on Pre-
ventive Health Care, Centre for Evidence-Based Medicine,
Centre for Evidence-based Health Care). The core project
team and expert advisory board will also provide input,
based on their knowledge of the potential participants, on
each participant’s level of expertise and potential for unique
contribution to the development of the guideline (e.g., stat-
istical expertise, information specialists). Participants will be
invited via personalized email that will describe the PRIOR
guideline development project and explain the objective,
process, and timelines of the Delphi exercise. We will ob-
tain informed consent from participants using an online
consent form.
Round one: Online survey
The participants will be asked to use a self-administered
online survey to rate, on a four-point Likert scale, the
extent to which they agree with the inclusion of each
checklist item in the PRIOR reporting guideline (1 =
strongly disagree, 2 = somewhat disagree, 3 = somewhat
agree, 4 = strongly agree) [34]. Participants may also
choose to answer “I don’t know” and provide an explan-
ation [35]. For each item, a free text box will be provided
for general comments (e.g., justification for their
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decision, proposed wording changes). Items will be pre-
sented in an order that reflects the progression of report-
ing in overviews (e.g., title, abstract, background, methods,
results, discussion, other). At the end of the survey, two
free text boxes will be provided for participants to suggest
additional checklist items, and relevant methods papers.
The Dillman principles for constructing respondent-
friendly web surveys will be used to design the survey and
its component items [36, 37]. Round one of the survey will
remain open for 1 month (February–March 2020), during
which bi-weekly reminder emails will be sent. The survey
will be completed quasi-anonymously (i.e., the core pro-
ject team but not the other study participants will know
the identities and responses of the participants [31]), using
a versatile online Delphi platform (e.g., Welphi). We will
collate and summarize survey results, with agreement de-
fined a priori as ≥ 70% for inclusion in (i.e., score of 3–4)
or exclusion from (i.e., score of 1–2) the reporting guide-
line [38], based on the total number of responses obtained
per question.
Round two: Online survey
In the second online survey (June–July 2020), the same
participants will view and/or re-rate the checklist items
presented in the first survey [32, 33]. The content, struc-
ture, and process will be similar to that of the first sur-
vey, with two differences. First, checklist items may be
re-worded and/or re-formatted (e.g., items may be split
or combined) based on the free-text comments collected
in the first survey. Second, we will provide participants
with their individual responses and a summary of anon-
ymized group ratings, including all free-text comments,
from the first survey. Participants will be asked to con-
sider the structured feedback to inform their responses
[32, 33]. Checklist items will be presented in the same
order as previously. The items that reached agreement
(≥ 70%) after the first survey will be presented for infor-
mation purposes only (i.e. no more voting will occur,
though participants may respond to free-text com-
ments). The items that did not reach a high level of
agreement during the first survey will be re-rated. The
participants will be asked to determine whether and how
they wish to modify their original answers in light of the
group responses and comments; they may also provide
feedback on free-text comments if desired. At the end of
the survey, we will ask the participants to rate and pro-
vide comments for each new checklist item generated by
participants during the first survey. We will collate and
summarize survey results, with agreement defined as
previously described (≥ 70%).
Round three: In-person meeting
With input from the advisory board, we will select and
invite a minimum of 8 to 10 participants (i.e., “expert
panelists”), ideally representing different stakeholder
groups, to convene at a 1-day, in-person meeting (Octo-
ber 2020), where a nominal group technique and real-
time voting will be used to systematically discuss and re-
solve outstanding disagreements [8, 33, 34]. If needed, a
subset of these expert panelists may participate remotely
using interactive software that allows for real-time
screen sharing, audio discussion, and user comments
(e.g., Adobe Connect, GoToMeeting). Moderators with
expertise in overview methods and previous experience
conducting consensus meetings for reporting guidelines
will facilitate the meeting. We will audio record the
meeting and take meeting minutes. The objective of the
meeting will be to obtain final agreement on the list of
items to be included in the PRIOR reporting guideline.
Prior to the meeting, members of the expert panel will
receive a copy of their second-round survey results. We
will begin the meeting by briefly summarizing the items
reaching agreement for inclusion in, and exclusion from,
the reporting guideline. No further voting will occur for
these items, but outstanding free-text comments will be
presented and resolved as needed; this could include
rewording or reformatting of existing items. The bulk of
the meeting will use a nominal group technique to ob-
tain a high level of agreement (i.e., ≥ 70% agreement, as
previously described) on those checklist items still lack-
ing agreement [33, 34]. Each item will be reviewed se-
quentially, using a three-step process. First, facilitators
will present the group survey results, all free-text com-
ments, and all relevant methodological literature related
to each item. This can help structure the interaction,
provide a common starting point for participants, and
promote evidence-based discussions about guideline
content [33]. Second, the expert panel will discuss, de-
bate, and aim to resolve discrepancies in a structured
large-group discussion [33, 34]. Third, expert panelists
will vote on the inclusion or exclusion of remaining
items from the guideline.
The expert panel will be asked to re-rate the extent to
which they agree with the inclusion of each checklist
item. The content, structure, and process of the survey
will be similar to the online surveys, with two changes:
(1) the “I don’t know” option will no longer be available
and (2) no free-text comments will be solicited. Expert
panelists will complete the survey anonymously using a
secure, online, live voting platform (e.g., Sli.do) that they
will access using their personal electronic devices, with
agreement defined as previously described (≥ 70%). Ag-
gregate survey results will be automatically compiled by
the software and presented to the group at the end of
the survey. If agreement has not been reached on all
items following the survey, we will ask the expert panel-
ists to divide themselves into one small group per check-
list item. Each small group will engage in unmoderated
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discussion to achieve final agreement, with rationale, for
each outstanding item. Post-meeting discussions may
continue over email or teleconference (i.e., including the
expert panelists and facilitated by the core team) to
achieve agreement, or we may implement an additional
online survey with expert panelists, if needed. The meet-
ing will conclude by discussing the strategy for produ-
cing, publishing, and disseminating the final guideline.
We will discuss the inclusion of a flow diagram, develop-
ment of an accompanying explanation and elaboration
document, who will be involved in which activities, and
publication and knowledge translation strategies [8].
Development of the guidance statement
A small writing group will iteratively draft the final ver-
sion of the PRIOR guidance document based on the final
decisions of the expert panel. The writing group will
consist of the core project team, with an open invitation
issued to the advisory board members and expert panel
members. We will aim to provide clear, concise, and un-
ambiguous wording for each PRIOR checklist item. The
reporting guideline will be circulated among all advisory
board members and expert panel members to obtain
final input and approval prior to publication.
Discussion
Despite the growing number of published overviews and
the commonly observed deficiencies in reporting of
overviews [2–4], there are currently no systematically
developed reporting guidelines for overviews of health-
care interventions. This protocol will help address this
gap in guidance by using a four-stage process to develop
the PRIOR reporting guideline, an evidence-based and
agreement-based reporting guideline for overviews of
healthcare interventions. Once completed, we will sub-
mit the PRIOR reporting guideline for publication to an
appropriate peer-reviewed journal (we may also seek co-
publication in multiple journals, if appropriate). The
guideline will also be published on the EQUATOR web-
site and the Cochrane Comparing Multiple Interventions
Methods Group (CMIMG) website. We will aim to
present the guideline at conferences and workshops, dis-
seminate the guideline via email lists, and solicit journal
editors to actively endorse the guideline. Other potential
methods that we will use to disseminate the guideline
could include videos, infographics, and social media.
The PRIOR reporting guideline will be developed
using a modified Delphi process, which is commonly
used to develop reporting guidelines in the health sci-
ences [11, 26]. There are established benefits to using a
modified Delphi process. For example, the online sur-
veys provide a time- and cost-effective way to obtain
preliminary agreement, while the more intensive in-
person meeting with nominal group technique allows for
face-to-face, in-depth discussion of outstanding issues
[33]. Using an explicit, controlled, and scientifically cred-
ible process to achieve a high level of agreement among
a group of experts can help to leverage the benefits of
individual expertise and group decision-making, while
simultaneously minimizing the biases associated with in-
formal decision-making [33]. This can enhance the cred-
ibility of the guideline development process and help to
ensure widespread acceptance and uptake of the report-
ing guideline. We expect some participant attrition be-
tween Delphi rounds; we will minimize this by following
Dillman’s principles [36, 37] and conducting pilot tests
to enhance the usability of the survey, providing bi-
weekly email reminders, and choosing a survey platform
that supports participant convenience by allowing them
to leave and return at any time. Additionally, the PRIOR
reporting guideline will only capture current expertise
based on the existing state of knowledge, and we expect
that requirements for reporting overviews will evolve
over time as overview methods evolve. Thus, the aim of
the PRIOR reporting guideline will not be to provide a
definitive or unchanging list of reporting requirements,
but rather to capture current expertise and knowledge
upon which future research can build.
Once completed, the planned work will result in an
evidence-informed, consensus-based reporting guideline
for overviews of reviews of healthcare interventions. The
PRIOR reporting guideline will help overview authors
improve the accuracy, completeness, and transparency
of reporting. It will also provide a framework for peer re-
viewers, journal editors, and healthcare decision-makers
to critically appraise submitted or published overviews.
Strengthening the reporting of overviews can help
healthcare decision-makers better evaluate the reliability,
validity, and applicability of overview results. This, in
turn, can maximize the impact of overviews by allowing
more accurate interpretation and use of their research
findings.
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